EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

08.04.18

António Campinos is Not Improving Patent Quality or Even the Social Climate at the EPO (False Promises)

Posted in Europe, Patents at 11:53 pm by Dr. Roy Schestowitz

Campinos says he wants to further increase so-called ‘production’ (beyond already-absurd [1, 2] levels)

Bureau of Engraving and Printing
Reference: Bureau of Engraving and Printing

Summary: Exploiting its immunity, the EPO continues to break the law and ignore court orders, rules, examination guidelines and even the EPC because the sole goal nowadays is granting as many patents as possible (even though examiners rightly object to that, citing relevant laws and public interest)

THE management of the EPO — like the management of the USPTO — strives to grant as many patents as possible. The reasons are selfish and purely economic (at the public’s expense). The law restricts its ability to do so, but the EPO famously disregards the law, e.g. when it comes to software patents in Europe (the original/early complaint we had about the EPO).

Have things improved under António Campinos? Of course not. We didn’t expect them to, either.

Here’s Jacobacci & Partners (Italy) lobbying for software patents in Europe (not quite legal) under the guise of "AI" — the guise facilitated/promoted by the EPO. IAM wrote the following a few days ago: “The patentability of artificial intelligence (AI) is a hot topic, mainly due to the tremendous expectations around this emerging, disruptive and pervasive technology. On 30 May 2018 the EPO held an international conference on patenting AI in Munich to explore this topic in detail. The EPO has recently published material and videos of the conference on the e-courses section of its website.”

So the EPO is basically saying, “call your software “AI” and then we’ll probably accept a patent on it.” The same goes for terms like “4IR” and several others. Over the past week alone the EPO wrote about half a dozen tweets to that effect.

One might then ask, “so has Campinos actually improved the climate?” (given that patent scope/quality remains a problem)

The answer appears to be no. SUEPO has just linked to a new article (behind paywall) about SUEPO and the new EPO President, Mr. Campinos. This was published [PDF] in SUEPO’s Web site just before the weekend. SUEPO seems to be growing impatient and as the article puts it: “Campinos’s insistence on maintaining the exhausting pace of patent grants while at the same time boosting patent quality is not a good sign. Campinos had one chance to make a good first impression but missed it by circumventing elected staff representatives and meeting directly with employees, a source close to the Staff Union of the EPO (SUEPO) said in an interview. Contrary to what Campinos trumpeted online, it does not appear to be a priority for him to work on the social agenda, said the source.”

So has anything at all improved under Campinos and his pretty much identical (to Battistelli’s) leadership? From what we can gather, things quieted down because the EPO isn’t saying much. But “quiet before the storm” comes to mind. And without a storm there’s no potential for any improvement/change.

A few days ago we learned about this company called Physna (“Physna is short for physical DNA,” it says) and saw this press release about “Cell and Gene Therapies” patents. Then came another press release, this one about RNA-related patents at the EPO. To quote:

RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA) therapeutic platform, announced today that the European Patent Office (EPO) and Japan Patent Office (JPO) have granted patents for the Company’s novel self-delivering RNAi (sd-rxRNA®) therapeutic platform. The EPO Patent #: 2949752 B1 and JPO Patent #: 620309 cover composition of matter, specifically structural and chemical attributes of sd-rxRNA. These patents will be set to expire in 2029.

So it certainly sounds as though the EPO still grants what we colloquially refer to as “patents on life”. Does it not matter that European authorities repeatedly say no to such patents? Does the EPO follow the law at all? Considering failure to obey court rulings (even by Campinos), this does not shock us.

Incidentally, a high European court (CJEU) — not just the political ‘pillar’ — has just weighed in on a related subject. To quote:

Last week, the CJEU ruled that organisms obtained by mutagenesis are genetically modified organisms (GMOs) and are, in principle, subject to the obligations laid down by the GMO Directive. The implication of this decision is that products produced by gene-editing techniques, such as CRISPR/Cas-9, will be subject to the same regulations as transgenic organisms. The Agritech industry has met the CJEU decision with dismay, arguing that it will further stifle agribiotech innovation in the EU.

[...]

In a dramatic turn-around, on 25th July 2018, the CJEU ruled that organisms obtained by mutagenesis are GMOs and are subject to the obligations laid down by the GMO Directive. The CJEU also particularly ruled that GMO Directive applies to organisms obtained by mutagenesis techniques that have been developed since adoption of the GMO Directive, reasoning that these techniques can now be used to produce organisms similar, from a risk perspective, to those that can be produced using transgenic methods.

In answer to the specific referred question as to whether organisms obtained by mutagenesis are excluded from the GMO Directive by Annex IB, the CJEU first noted that, under EU law, the GMO Directive should be interpreted by consideration of not only its wording “but also the context in which it occurs and the objectives”. The Court noted that the objective of the wording of Annex IB was to exclude organisms that are “obtained through certain techniques of genetic modification which have conventionally been used in a number of applications and have a long safety record”.

[...]

Gene editing technologies are immensely valuable from a research perspective. The relatively permissive regulatory environment for the cultivation of gene edited organisms in the EU also provided a clear commercial advantage to the technologies over transgenics. The CJEU decision has been so far met with dismay by the industry, with the outcry that “classification of genome-edited organisms as falling under the GMO Directive could slam the door shut on this revolutionary technology” (source: Rothamsted Research). Are we likely to see a falling-off in European patent filings directed at gene edited organisms? At the very least, we may expect the urgency to specifically claim a gene edited form of GMO products to lessen.

Following the EPO decision last year in Tomatoes II G 2/12 and Broccoli-II G 2/13, together with the latest CJEU decision, the agritech industry faces ongoing challenges to the development of new plant products in the EU. On the one hand, plants and plant products produced by “natural” breeding methods cannot be protected under the patent system, whilst plants and plant products produced by transgenic, and now gene editing, techniques, are subject to crippling legislation. The EPO and EU must of course balance the promotion of innovation with ethical concerns regarding genetic modification, but has the right balance been struck?

A bunch of comments have been posted there since then, notably those dealing with health implications, including in the case below (potentially) ISDS:

In those matters the precautionary principle should prevail, and I am inclined to find the decision very wise.

I have read some reports that the famous CRISPR/Cas-9 techniques are by far not as precise as it was made us to believe. In this respect, the decision is fully justified.

The safety of the methods themselves, be it for transgenic or mutagenetic modifications, and their impact on our environment has by no means be demonstrated.

The safety regulators are still too much influenced by large lobby groups, when they do not simply put their name on documents provided by industry.

People in Europe are not ready to swallow everything which is put in their dishes, and it is good so.

When looking at the latest blog published on Kluwer Patent blog,

http://patentblog.kluweriplaw.com/2018/08/01/international-investment-arbitration-extraordinary-remedy-concerning-decisions-european-patent-office-future-unified-patent-court/

I would not be surprised if firms engaged in these techniques will not end up with bringing States before arbitration chambers, the legality and usefulness of which has still to be demonstrated.

Notice how UPC is being exploited by patent maximalists before it even exists (it will never exist). A timely reminder of the agenda of EPO management, which exploits its immunity to ignore the law, disregard the courts and basically grant patents on just about anything.

We’ll deal with the UPC in our next post.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 18/3/2019: Solus 4, Linux 5.1 RC1, Mesa 18.3.5, OSI Individual Member Election Won by Microsoft

    Links for the day



  2. Microsoft and Its Patent Trolls Continue Their Patent War, Including the War on Linux

    Microsoft is still preying on GNU/Linux using patents, notably software patents; it wants billions of dollars served on a silver platter in spite of claims that it reached a “truce” by joining the Open Invention Network and joining the LOT Network



  3. Director Iancu Generally Viewed as a Lapdog of Patent Trolls

    As Director of the Office, Mr. Iancu, a Trump appointee, not only fails to curb patent trolls; he actively defends them and he lowers barriers in order to better equip them with bogus patents that courts would reject (if the targets of extortion could afford a day in court)



  4. Links 17/3/2019: Google Console and IBM-Red Hat Merger Delay?

    Links for the day



  5. To Team UPC the Unified Patent Court (UPC) Has Become a Joke and the European Patent Office (EPO) Never Mentions It Anymore

    The EPO's frantic rally to the very bottom of patent quality may be celebrated by obedient media and patent law firms; to people who actually produce innovative things, however, this should be a worrisome trend and thankfully courts are getting in the way of this nefarious agenda; one of these courts is the FCC in Germany



  6. Links 16/3/2019: Knoppix Release and SUSE Independence

    Links for the day



  7. Stopping António Campinos and His Software Patents Agenda (Not Legal in Europe) Would Require Independent Courts

    Software patents continue to be granted (new tricks, loopholes and buzzwords) and judges who can put an end to that are being actively assaulted by those who aren't supposed to have any authority whatsoever over them (for decisions to be impartially delivered)



  8. The Linux Foundation Needs to Speak Out Against Microsoft's Ongoing (Continued) Patent Shakedown of OEMs That Ship Linux

    Zemlin actively thanks Microsoft while taking Microsoft money; he meanwhile ignores how Microsoft viciously attacks Linux using patents, revealing the degree to which his foundation, the “Linux Foundation” (not about Linux anymore, better described as Zemlin’s PAC), has been compromised



  9. Links 15/3/2019: Linux 5.0.2, Sublime Text 3.2

    Links for the day



  10. The EPO and the USPTO Are Granting Fake Patents on Software, Knowing That Courts Would Reject These

    Office management encourages applicants to send over patent applications that are laughable while depriving examiners the freedom and the time they need to reject these; it means that loads of bogus patents are being granted, enshrined as weapons that trolls can use to extort small companies outside the courtroom



  11. CommunityBridge is a Cynical Microsoft-Funded Effort to Show Zemlin Works for 'Community', Not Microsoft

    After disbanding community participation in the Board (but there are Microsoft staff on the Board now) the "Linux Foundation" (or Zemlin PAC) continues to take Microsoft money and polishes or launders that as "community"



  12. Links 14/3/2019: GNOME 3.32 and Mesa 19.0.0 Released

    Links for the day



  13. EPO 'Results' Are, As Usual, Not Measured Correctly

    The supranational monopoly, a monopoly-granting authority, is being used by António Campinos to grant an insane amount of monopolies whose merit is dubious and whose impact on Europe will be a net negative



  14. Good News Everyone! UPC Ready to Go... in 2015!

    Benoît Battistelli is no longer in Office and his fantasy (patent lawyers' fantasy) is as elusive as ever; Team UPC is trying to associate opposition to UPC with the far right (AfD) once again



  15. Links 13/3/2019: Plasma 5.15.3,Chrome 73 and Many LF Press Releases

    Links for the day



  16. In the Age of Trumpism EFF Needs to Repeatedly Remind Director Iancu That He is Not a Judge and He Cannot Ignore the Courts

    The nonchalance and carelessness seen in Iancu's decision to just cherry-pick decisions/outcomes (basically ignoring caselaw) concerns technologists, who rightly view him as a 'mole' of the litigation 'industry' (which he came from)



  17. Links 12/3/2019: Sway 1.0 Released, Debian Feuds Carry On

    Links for the day



  18. Microsoft is Complaining About Android and Chrome OS (GNU/Linux) Vendor Not Paying for Microsoft Patents (Updated)

    Microsoft, which nowadays does the patent shakedown against GNU/Linux by proxy, is still moaning about companies that don’t pay ‘protection’ money (grounds for antitrust action or racketeering investigation)



  19. Watchtroll Has Redefined "Trolls" to Mean Those Who Oppose Software Patents (and Oppose Trolls), Not Those Who Leverage These for Blackmail Alone

    The controversial change to 35 U.S.C. § 101 guidance is being opposed by the public (US citizens who oppose American software patents), so patent maximalists like Janal Kalis (“PatentBuddy”) and extremists like Gene Quinn (Watchtroll) want us to believe that the public is just “EFF” and cannot think for itself



  20. EPO's Latest 'Results' Show That António Campinos Has Already Given Up on Patent Quality and is Just Another Battistelli

    The patent-granting machine that the EPO has become reports granting growth of unrealistic scale (unless no proper examination is actually carried out)



  21. Links 11/3/2019: Linux 5.0.1, Audacity 2.3.1, GNU Coreutils 8.31

    Links for the day



  22. US Patent Law Currently Not Changing Much and Software Patents Are Still in Limbo

    Surveying the news, as we still meticulously do (even if we don't write about it), it seems clear that American courts hardly tolerate software patents and proponents of such patents are losing their voice (or morale)



  23. EPO Examiner: “I Have Been Against Software Patents and Eventually 3/4 of My Job is Examining Software Patent Applications.”

    Overworked examiners aren't being given the time, the tools and the freedom to reject patents, based on prior art, patent scope and so on; it is beginning to resemble a rubber-stamping operation, not an examining authority



  24. Europe Will Pay a High Price for Software Patents Advocacy by António Campinos in Europe's Patent-Granting Authority

    EPO President António Campinos — like Iancu at the U.S. Patent and Trademark Office (USPTO) — is still promoting software patents in Europe even though such patents are clearly detrimental to Europe’s interests



  25. António Campinos -- Like His Father -- Lacks Support From Colleagues, Endorsed Only From the Top

    History lessons from Wikileaks



  26. Links 10/3/2019: GNU and GNOME Releases

    Links for the day



  27. Koch Brothers' Oil Money is Poisoning Academia and Distorting Scholarly Work/Research on Patents

    Meddling in patent law by the Kochs, the oil tycoons who can be seen everywhere Conservative think tanks are, shows no signs of abatement



  28. From Patents on Chewing Gum to Toothpaste Patents: How the EPO Came to Focus on Speed and Volume, Not Quality

    There’s still no proper quality control in place for European Patents — a severe problem which will only further exacerbate the legal uncertainty associated with all European Patents



  29. European Patent Office Press Releases (Two in Two Days) Are Disguised as 'News' and Tell the Opposite of the Truth

    The Office under the 'new' and 'improved' leadership of António Campinos seems to be repeating the mistakes of Battistelli by discrediting anything it says; its press releases, characteristically dubbed "news" for some reason, bear no resemblance to reality and are detached from facts EPO insiders have long known



  30. Links 9/3/2019: International Women’s Day, QtLottie

    Links for the day


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts